International Journal of Recent Innovations in Medicine and Clinical Research (IJRIMCR) is an International, Peer-Reviewed and Open Access Journal Published Quarterly.
The following manuscripts will be considered for publication
- Research Articles
- Review Articles
- Mini Reviews
- Case Studies and
- Short Communications
Submission of Manuscript
Manuscript should be written in English language. The text should be in Times New Roman font, size 12, 1.5 line spaced throughout the manuscript. It is recommended to submit the manuscript in all respect tables, figures and graphs in single word file at: email@example.com for quick evaluation process. Authors should declare that the submitting manuscript is unique and has not been published earlier or under consideration for publication while being evaluated for IJRIMCR.
Page Limit for Manuscripts
The authors are requested to check their length of the manuscript in between 20-35 pages. If the content is of high value, the editorial office of IJRIMCR will accept any manuscript which is either shorter or longer than the prescribed page limit.
The following sequence should be followed while preparing manuscript
Title should be concise and informative; it is reflecting the scope, purpose and content of the study. Authors are requested to include their affliction, contact details, active E-mail addresses.
Abstract should be the aim and scope of the work undertaken by authors. It should be brief and concise not exceeding 350 words.
Provide maximum of 6 keywords and they are reflecting the major concepts of the research work, each one is separated by comma (Example: Asthma, Lung Cancer, Clinical Research, Hormones, Metabolites).
The introduction should state the main objective of the research work and avoid a detailed literature survey or a summary of the results.
Material and Methods
Material and Methods should be clearly presented in the submitting manuscript to allow the reproduction of the experiments. With reference to human/animal experimentation ethical guidelines should be followed.
Results and Discussion
Results and Discussion sections may be combined or separated.
Major importance of the study undertaken, and their relevance shall be précised at the end of the manuscript before Acknowledgments section with possible suggested recommendations.
Acknowledgements of Institutions, Supporting Industries, People and Funding Agencies should be brief.
Tables and Figures
Tables and Figures should be numbered consecutively with Arabic Numerals (Table 1, Table 2, Table 3, Figure 1, Figure 2 and Figure 3….) and must be cited in the text. Short table title should be recommended. Keep the table title on top and figure legend should be on the bottom.
Model Table and Figure
References should be numbered consecutively starting from 1, and should be cited in the manuscript by numbers, e.g. [1, 2, 3, 4, 5……..], (not cited by author and date). One article per reference only (not 1a, 1b, 1c). Please avoid putting personal communications, unpublished observations, conference abstracts or conference papers in references. Do not format references as footnotes. Please use plain text in references, no image or math equation.
Please note the number of references must not exceed 200 for any article.
Use the sequence: [Author surname] [Author initials], [Other author surnames & initials]. [Article title]. [Journal name abbreviation]. [Year]; [Volume]: [First page number]-[Last page number].
- Journal paper must have journal name (or journal abbreviation), year, volume and page numbers.
- Please make sure that the year of publication is not missing.
- Please use “:” to separate volume and first page number.
- Do not bold or italicize the title, journal name, or any part of references. Omit any “.” in the journal abbreviations.
- Please do not add web links or web URLs in references.
- Freedland SJ, Csathy GS, Frederick D, et al. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol. 2002;167:516–520.
- Samphao S, Eremin JM, El-Sheemy M, Eremin O. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach. Ann Surg Oncol. 2008 May;15(5):1282-96.
- Newman EA, Newman LA. Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin North Am. 2007;87(2):353-64.
- Sandhu S, Farag E, Argalious M. Anaphylaxis to isosulfan blue dye during sentinel lymph node biopsy. J Clin Anesth. 2005 Dec;17(8):633-5.
- Paller AS, Pensler JM, Tomita T. Nasal midline masses in infant and children. Dermoid cyst, encephalocele and glioma. Arch Dermatol. 1991;12(7):362-366.
- Morgan DW, Evans JN. Developmental nasal anomalies. J Laryngol Otol. 1990;10(4):394-403.
- Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996;22(Suppl 4):S474-S481.
No Author Given Example
- [No authors listed]. Medicare program; criteria for Medicare coverage of adult liver transplants-HCFA. Final notice. Fed Regist. 1991;56(71):15006-15018.
In Press Example
- Cheung TMT, et al. Effectiveness of non-invasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome. Chest; in press.
Epub Ahead of Print Example
- Li W, Chen Y, Cameron DJ, et al. Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice. Vision Res 2007; [Epub ahead of print].
- Kiloh LG, Smith JS, Johnson GF, et al. Physical treatment in psychiatry. Boston, USA: Blackwell Scientific Publisher; 1988.
Chapters in Edited Book
- Beckenbough RD, Linscheid RL. Arthroplasty in the hand and wrist. In: Green DP, ed. Operative Hand Surgery, 2nd ed. New York: Churchill Livingstone; 1988:167-214.
Web Site (discouraged)
- [Internet] WHO: Geneva, Switzerland. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. http://www.who.int/
- [Internet] Kornberg R. http://nobelprize.org/
Web pages and Web links
We strongly discourage any mentioning or citing web links/URLs in your paper, since web addresses are changed frequently by their owners. This often results in broken links (dead links) in your paper in the future. It is annoying if readers cannot find the web pages when clicking on the links.
Please use the following link to check the complete information for Samples of Formatted References for Authors of Journal Articles
The chemical nomenclature used must be in accordance with that used in the Chemical Abstracts.
(Examples: Pseudomonas aeruginosa, Candida albicans, Streptococcus mutans).
The trivial names recommended by the IUPAC-IUB Commission should be used. When the enzyme is the main subject of a paper, its code number and systematic name should be stated in its first citation in the paper.
For Animal and Clinical Experiments
must be a clear statement while submitting that, investigations using
experimental animals were conducted in accordance with the
internationally accepted principles for laboratory animal use and
care as found in for example the European Community guidelines (EEC
Directive of 1986; 86/609/EEC) or the US guidelines (NIH publication
#85-23, revised in 1985). Investigations with human subjects must
state that the research followed guidelines of the Declaration of
Helsinki and Tokyo for humans, and was approved by the institutional
human experimentation committee or equivalent, and that informed
consent was obtained. For reports of randomized, controlled trials,
authors should refer to the CONSORT statement. This guideline
provides a set of recommendations comprising a list of items to
report and a patient flow diagram.
Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA (animal) and ICMR (human). The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section.
Abbreviations and Units
Generally, units must be abbreviated according to the International System of Units (SI units).
Below you find the examples of abbreviations of the most commonly used SI units:
Units forLength (m, cm, m, mm, nm, Å)
Units forMass (kg, g, mg, mg, ng, pg, mol, mmol)
Units forVolume (l, ml, ml), time (s, min, h, d)
Units forTemperature (°C, K)
Units forRadiation (Bq, Ci, dpm, Gy, rad) and
Units forConcentration (M, mM, mol/l, mmol/l, mg/ml, mg/ml, %, % (v/v), % (w/v), ppm, ppb.
Proofs and Reprints
Proofs will be sent via e-mail as an Acrobat PDF file (e-mail attachment) and should be returned within four days of receipt. Page proofs are considered to be the final version of the manuscript. With the exception of typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. Authors will have free electronic access to the full text (PDF) of the article. Authors can freely download the PDF file from which they can print unlimited copies of their articles.
IJRIMCR issue Acceptance Certificate to Author(s) for manuscripts that have been reviewed and accepted for publication by an Editor-in-Chief.
After the article is made available on the journal’s website, a publication notice is sent to the corresponding author with links to the issue and article.
Copyright and Open Access Statement
Submission of a manuscript implies that the work described has not been published before (except in the form of an abstract or as part of a published lecture, or thesis) and that it is not under consideration for publication elsewhere.
All works published by International Journal of Recent Innovations in Medicine and Clinical Research (IJRIMCR) are under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited.
Article Processing Charges
For Indians: Rs. 3,500/-
For Overseas Authors
Authors from High Income Countries: 350 USD
Authors from Upper Middle Income Countries: 220 USD
Authors from Lower Middle Income Countries: 100 USD
Authors from Low Income Countries: 60 USD
Waiver Policy of the Journal
The IJRIMCR does not charge any article submission fee. Authors are requested to pay a fair manuscript handling fee for the processing of their articles when an article is accepted, processed, reviewed and authorized for publication.
IJRIMCR is a self-supporting International Journal and does not receive funding from any institution/government. Hence, the operation of the Journal is solely financed by the handling fees received from authors. The handling fees are required to meet expenses such as peer review, internet services, indexing of articles, copy-editing, web-hosting, application development and support, electricity etc.
IJRIMCR may grant the partial waiver in article processing charges to those authors who are unable to pay the Article Processing Charges due to financial crisis. Only the authors from low income and middle income countries can apply for waiver. Waiver is applicable for one article per year for each submitting author.
Fee waiver requests must be directed to the Editor-In-Chief using the following E-mail: firstname.lastname@example.org.
Note: All The Transaction Charges or Service Charges will be Pay by Author (Inter and Intra Banking Charges, Internet Banking Charges, Western Union Transfer Charges, Pay-Pal Charges, MoneyGram, NEFT Charges etc.).
Manuscript Withdrawal Policy and Charges
The corresponding author is allowed to withdraw the manuscript without paying any withdrawal penalty, if the author(s) requests a withdrawal of manuscript, within two days of submission.
If the author(s) requests a withdrawal of manuscript, after the peer review process or in the production stage (Early Release or Ahead of publishing) or published online; then authors need to make a withdrawal penalty.
IJRIMCR Editorial Office will provide the corresponding author a formal letter of Manuscript Withdrawal. Withdrawal of manuscripts is only allowed after withdrawal penalty (30% of the total fee) has been fully paid to the IJRIMCR Editorial Office.
As per the policy, we declare that the withdrawal charges are applicable in case of withdrawal (30% of the total fee).
If the author withdraws the article after acceptance or after publication of the manuscript and payment has also been made, there will be NO REFUND of the Article Processing Charge (APC) already paid. If a Manuscript is withdrawn over indexing issues, NO REFUND will be made.
If the author wish to withdraw paper from a journal, author needs to submit an “Article withdrawal Form” signed by all authors (or) the corresponding author of the manuscript stating the reasons for manuscript withdrawal. The form is available from the Editorial Office of the journal.
Manuscript Submission Checklist
Authors are requested to check the following list carefully
1) Font Size and Line Spacing: Times New Roman 12 and 1.5 line Spaced throughout the manuscript.
2) Plagiarism Percentage: Plagiarism content should be less than 20%.
3) High Resolution (Quality) figures are enclosed.
3) Manuscript should be in a single file along with tables, figures and graphs.
4) Name, address, telephone number, and active e-mail address of the corresponding author.
5) Tables and Figures are cited in numeric sequence in the text.
6) Figures should be submitted in PDF, JPEG, EPS, or TIFF format.
7) All references have been checked for accuracy and completeness.
8) Species names should be in italics.
9) Manuscript has been grammar checked and spell-checked.
10) Clinical trial registration number, if applicable.
11) References should be in Journal Guidelines format.
Note: Authors are encouraged to refer to the latest issue of IJRIMCR for the format of manuscript preparation.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.